BostonGene: Joe Lennerz, Mark Hiatt, Ned Segal

BostonGene has appointed Joe Lennerz as CSO, Mark Hiatt as senior VP of market access and strategy, and Ned Segal as a member of the board of directors. 

Lennerz previously served as associate chief of pathology and medical director of the Center for Integrated Diagnostics at Massachusetts General Hospital and Harvard Medical School. Hiatt previously served as VP of medical affairs for Guardant Health, executive medical director for Regence BlueCross BlueShield, and chief medical officer for HealthHelp. Segal previously served as CFO of Twitter, senior VP of finance at Intuit's Small Business Group, and CFO at patent risk management company RPX. He most recently served as managing director and head of global software investment banking at Goldman Sachs and is a board member at RingCentral and Beyond Meat.